Zobrazeno 1 - 10
of 168
pro vyhledávání: '"Theodore K, Marras"'
Autor:
Samantha J. Bents, Rachel A. Mercaldo, Collin Powell, Emily Henkle, Theodore K. Marras, D. Rebecca Prevots
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background Nontuberculous mycobacteria (NTM) are ubiquitous environmental bacteria that cause chronic lung disease. Rates of NTM pulmonary disease (NTM PD) have increased over the last several decades, yet national estimates in the United St
Externí odkaz:
https://doaj.org/article/fcdfda83bcd6481a9dd89532b7d5ae93
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-11 (2023)
Abstract Background Chronic obstructive pulmonary disease (COPD) is a common comorbidity in patients with nontuberculous mycobacterial lung disease (NTMLD). Both conditions are associated with increased morbidity and mortality, but data are lacking o
Externí odkaz:
https://doaj.org/article/587ed024a1f84a578df3408b01b594c6
Autor:
Theodore K. Marras, Paul Nelson, Adriana Peci, Melissa Richard-Greenblatt, Sarah Brode, Ashleigh Sullivan, Frances B. Jamieson, Julianne V. Kus
Publikováno v:
Emerging Infectious Diseases, Vol 29, Iss 7, Pp 1415-1419 (2023)
We measured annual prevalence of microbiologically defined nontuberculous mycobacterial lung disease in Ontario, Canada. Mycobacterium avium prevalence was 13 cases/100,000 persons in 2020, a 2.5-fold increase from 2010, indicating a large increase i
Externí odkaz:
https://doaj.org/article/390bc03cb11746cb949454b7df34c766
Publikováno v:
Emerging Infectious Diseases, Vol 28, Iss 8, Pp 1589-1596 (2022)
In mid-2014, Public Health Ontario Laboratories identified coincident increasing Mycobacterium avium isolation and falling M. xenopi isolation in the Toronto, Ontario, Canada, area. We performed a retrospective cohort of all patients in a Toronto cli
Externí odkaz:
https://doaj.org/article/cb7e56ae67004fbcbdbb6ce3703f0722
Autor:
Huda Asif, Franck F. Rahaghi, Akihiro Ohsumi, Julie Philley, Amir Emtiazjoo, Takashi Hirama, Arthur W. Baker, Chin-Chung Shu, Fernanda Silveira, Vincent Poulin, Pete Rizzuto, Miki Nagao, Pierre-Régis Burgel, Steve Hays, Timothy Aksamit, Takeshi Kawasaki, Charles Dela Cruz, Stefano Aliberti, Takahiro Nakajima, Stephen Ruoss, Theodore K. Marras, Gregory I. Snell, Kevin Winthrop, Mehdi Mirsaeidi
Publikováno v:
ERJ Open Research, Vol 9, Iss 2 (2023)
Rationale Nontuberculous mycobacterial (NTM) diseases are difficult-to-treat infections, especially in lung transplant (LTx) candidates. Currently, there is a paucity of recommendations on the management of NTM infections in LTx, focusing on Mycobact
Externí odkaz:
https://doaj.org/article/4c7d713812a8438997c0717e1067401e
Autor:
Theodore K. Marras, Mariam Hassan, Kevin C. Mange, Monika Ciesielska, Shilpa Dhar Murthy, Zhanna Jumadilova, Anjan Chatterjee
Publikováno v:
ERJ Open Research, Vol 8, Iss 3 (2022)
Externí odkaz:
https://doaj.org/article/cbc83b69f5b94fd3a566773c04c2a933
Autor:
Lauren C. Ramsay, Emily Shing, John Wang, Theodore K. Marras, Jeffrey C. Kwong, Sarah K. Brode, Frances B. Jamieson, Beate Sander
Publikováno v:
Emerging Infectious Diseases, Vol 26, Iss 9, Pp 2097-2107 (2020)
To determine incidence-based healthcare costs attributable to nontuberculous mycobacterial (NTM) pulmonary disease (PD) and NTM pulmonary isolation (PI), from the healthcare payer perspective, we conducted a population-based matched cohort study in O
Externí odkaz:
https://doaj.org/article/fd3d774d807a45b68cc53f40ce1568fa
Autor:
Sarah K. Brode, Hannah Chung, Michael A. Campitelli, Jeffrey C. Kwong, Alex Marchand-Austin, Kevin L. Winthrop, Frances B. Jamieson, Theodore K. Marras
Publikováno v:
Emerging Infectious Diseases, Vol 25, Iss 7, Pp 1271-1280 (2019)
Surveys suggest that clinicians diverge from guidelines when treating Mycobacterium avium complex (MAC) pulmonary disease (PD). To determine prescribing patterns, we conducted a cohort study of adults >66 years of age in Ontario, Canada, with MAC or
Externí odkaz:
https://doaj.org/article/41e01e6e15ab4c548719949d32aca233
Publikováno v:
BMC Pharmacology and Toxicology, Vol 20, Iss 1, Pp 1-9 (2019)
Abstract Background Treatment guidelines suggest either a low-dose or high-dose approach when prescribing amikacin for nontuberculous mycobacterial pulmonary disease (NTM PD), but data supporting the low-dose approach are limited. The purpose of this
Externí odkaz:
https://doaj.org/article/a4e45201c8134e809fc4ddd9332bdcf7
Publikováno v:
Journal of Managed Care & Specialty Pharmacy. :1-11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f33ed9ae9ef025a74e58c8ca11ed7fa
https://doi.org/10.18553/jmcp.2023.22417
https://doi.org/10.18553/jmcp.2023.22417